Literature DB >> 718345

Pain of terminal cancer patients.

M W Oster, M Vizel, L R Turgeon.   

Abstract

The belief that cancer inevitably leads to a painful death is widespread. This may contribute to society's "cancerophobia" with subsequent frequent delays in seeking medical attention for suspected malignant neoplasms. We evaluated the degree of pain experienced by dying patients, with and without cancer, at a large medical center. Patterns of analgesic administration and physician and nurse progress notes demonstrated that patients dying with cancer had significantly higher preterminal daily pain ratings and significantly fewer pain-free days than patients dying without cancer (P less than .01). Nevertheless, approximately one quarter of cancer patients died without any pain or analgesic administration. A painful death from cancer is thus not inevitable.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718345

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

Review 1.  The vanilloid agonist resiniferatoxin for interventional-based pain control.

Authors:  Michael J Iadarola; Andrew J Mannes
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

2.  [Pain relief in the final stage of cancer.].

Authors:  S Grond; D Zech; G Horrichs-Haermeyer; K A Lehmann
Journal:  Schmerz       Date:  1990-03       Impact factor: 1.107

3.  [Oral and maxillofacial cancer pain therapy with sublingual buprenorphine.].

Authors:  G Hotz
Journal:  Schmerz       Date:  1988-03       Impact factor: 1.107

Review 4.  Drug management of pain in cancer patients.

Authors:  C B Tuttle
Journal:  Can Med Assoc J       Date:  1985-01-15       Impact factor: 8.262

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.